Grant Nash
Fortuna: 58 914 $ al 31/05/2026
Fortuna: 58 914 $ al 31/05/2026
Mr. Grant R.
Nash is a CFO, COO, Secretary & Executive Director at Ixico Plc.
He is on the Board of Directors at Ixico Plc.
Mr. Nash was previously employed as a Finance Director by UK Biobank Ltd. and a Senior Vice President-Finance by Evotec (UK) Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IXICO PLC 0,23 % | 08/12/2025 | 505.263 ( 0,23 % ) | 58 914 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IXICO PLC | Director Financiero/CFO | 21/08/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
UK Biobank Ltd.
UK Biobank Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit healthcare research organization and laboratory | Director Financiero/CFO | 01/04/2019 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences and engineering | Corporate Officer/Principal | 01/02/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Ixico Plc
Ixico Plc Miscellaneous Commercial ServicesCommercial Services Operates as a medical imaging company that provides imaging biomarkers for clinical trials, research studies and diagnostics | Commercial Services |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences and engineering | Commercial Services |
UK Biobank Ltd.
UK Biobank Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit healthcare research organization and laboratory | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.